🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Nonrandomized, prospective, observational, multi-site registry to assess lo...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00705419
This is a double-blind Phase 2a study to test the safety and efficacy of an...
Status
Terminated
Location
Research Site
Start Date
2012-12
Trial ID
NCT01737359
Treatments Being Tested
The HIV-2 is less common ie 1-2 million people in West Africa. HIV-2 does h...
Status
Completed
Location
Hôpital Bichat-Claude Bernard
Start Date
2012-07
Trial ID
NCT01605890
Treatments Being Tested
The primary objective of this study in antiretroviral (ARV)-naïve Human imm...
Status
Terminated
Location
Multiple Locations
Start Date
2012-07-31
Trial ID
NCT01620944
Treatments Being Tested
The primary objectives of this study are to evaluate the efficacy, safety, ...
Status
Completed
Location
Multiple Locations
Start Date
2016-12-29
Trial ID
NCT02979613
Treatments Being Tested
Entecavir, a potent antiviral agent, has been widely used for treatment-naï...
Status
Completed
Location
Korea University Ansan Hospital
Start Date
2013-04
Trial ID
NCT01711567
The purpose of this randomized, open-label, multicenter, active-controlled ...
Status
Completed
Location
University of Alabama - Birmingham
Start Date
2010-11
Trial ID
NCT01252940
Treatments Being Tested
This randomized trial compares the efficacy of switching to a fixed-dose co...
Status
Unknown
Location
GHESKIO
Start Date
2020-09-01
Trial ID
NCT04311957
Treatments Being Tested
The main purpose of this study was to compare the effects on bones of the f...
Status
Completed
Location
31788 Alabama CRS
Start Date
2012-01-17
Trial ID
NCT01400412
Prospective, open, single-arm trial of dolutegravir-tenofovir and emtricita...
Status
Completed
Location
Fundacion Huesped
Start Date
2015-12
Trial ID
NCT03033836
Treatments Being Tested